Foxo Technologies Inc
FOXO0.152USD
-0.004-2.82%
取引時間 （ET）15分遅れの株価
51.97K時価総額
損失額直近12ヶ月PER
詳細情報 Foxo Technologies Inc 企業名
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
企業情報
企業コードFOXO
会社名Foxo Technologies Inc
上場日Dec 11, 2020
最高経営責任者「CEO」Mr. Seamus Lagan
従業員数- -
証券種類Ordinary Share
決算期末Dec 11
本社所在地477 South Rosemary Avenue
都市WEST PALM BEACH
証券取引所NYSE American Consolidated
国United States of America
郵便番号33401
電話番号16128000059
ウェブサイトhttp://delwinds.com/
企業コードFOXO
上場日Dec 11, 2020
最高経営責任者「CEO」Mr. Seamus Lagan
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
株主統計
種類
株主統計
株主統計
比率
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
株主統計
株主統計
比率
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
種類
株主統計
比率
Corporation
1.75%
Investment Advisor
0.21%
Investment Advisor/Hedge Fund
0.17%
Research Firm
0.05%
Hedge Fund
0.03%
Other
97.80%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
42
117.55K
2.20%
-40.11K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Rennova Health, Inc.
102.36K
0.96%
-1.00
-0.00%
May 21, 2025
Clearthink Capital Partners LLC
60.00K
0.56%
+60.00K
--
Dec 01, 2023
Kr8 ai Inc
23.70K
0.22%
-1.00
-0.00%
May 21, 2025
UBS Financial Services, Inc.
15.02K
0.14%
+1.03K
+7.33%
Mar 31, 2025
Geode Capital Management, L.L.C.
14.40K
0.14%
+10.16K
+239.24%
Mar 31, 2025
SBI Securities Co., Ltd.
5.10K
0.05%
+1.17K
+29.67%
Mar 31, 2025
Corbin Capital Partners, L.P.
2.75K
0.03%
--
--
Dec 31, 2024
Capital Investment Advisory Services, LLC
2.50K
0.02%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.42K
0.02%
--
--
Mar 31, 2025
State Street Global Advisors (US)
2.00K
0.02%
--
--
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
日付
種類
比率
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
